Ordering
Available Variants100 mg
CHA.97692-100mg
Price
€142.40
Available – Dispatch in 14 days
500 mg
CHA.97692-500mg
Price
€659.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.97692-100mg | €142.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
500 mg | CHA.97692-500mg | €659.20 |
≥99.0% (HPLC), ≥99%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C11H14N2O |
|---|---|
| CAS Number | 485-35-8 |
| Molecular Weight | 190.24 |
| NACRES | NA.22 |
| PubChem Substance ID | 329763123 |
| UNSPSC Code | 12352200 |
| EC Number | 207-616-0 |
| MDL number | MFCD00136048 |
| Assay | ≥99%, ≥99.0% (HPLC) |
| Form | powder |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H301 + H311 + H331 |
| pcodes | P261 - P264 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P311 |
| Hazard Classifications | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
Cytisine, with the chemical formula C10H12N2 and CAS number 485-35-8, is a quinolizidine alkaloid found in certain plant species, particularly in the genus Cytisus, from which it derives its name. This compound has been identified as a partial agonist of the nicotinic acetylcholine receptor, exhibiting a high affinity for these receptors. As a result, cytisine has been investigated for its potential therapeutic applications, including the treatment of nicotine addiction and other conditions related to nicotinic receptor dysfunction. Its mechanism of action involves the activation of nicotinic receptors, which can lead to the reduction of nicotine cravings and withdrawal symptoms. Cytisine has been used in some countries as a smoking cessation aid, with studies suggesting its efficacy in this regard, although further research is needed to fully understand its effects and potential side effects.
